Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: Effect of exenatide

Saudi Journal of Gastroenterology

Volumn 16, Issue 3, 2010, Pages 174-180

  Vaghasiya, Jitendra D ^a   Sheth, Navin R ^b   Bhalodia, Yagnik S ^a   Jivani, Nurudin P ^a  

^a Department of Pharmacology Smt RBPMPC ^*  (India)

^b SAURASHTRA UNIVERSITY   (India)

Author keywords

diabetes type 2; Exenatide; ischemia reperfusion; liver injury; oxidative stress

Indexed keywords

CATALASE; CREATINE KINASE; EXENDIN 4; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIVER ENZYME; MYELOPEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; PEPTIDE; VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; KIDNEY ISCHEMIA; LIPID PEROXIDATION; LIVER INJURY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; REPERFUSION INJURY; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; KIDNEY; KIDNEY DISEASES; LIVER; LIVER DISEASES; LIVER FUNCTION TEST; METABOLISM; VASCULARIZATION; WISTAR RAT;

ANIMALS; CATALASE; CREATINE KINASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; NITRIC OXIDE; PEPTIDES; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VENOMS; XANTHINE OXIDASE;

EID: 77954780042     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.65187     Document Type: Article

References (36)

1. Sural S, Sharma RK, Gupta A, Sharma AP, Gulati S. Acute renal failure associated with liver disease in India: Etiology and outcome. Ren Fail 2000;22:623-634
2. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-1139
3. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657
4. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC. Ischemia causes rapidly progssive nephropathy in the diabetic rat. Kidney Int 1997;52:985-991
5. Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON. Changes in hepatic TNF-a levels, antioxidant status, and oxidation product after renal ischemia/ reperfusion injury in mice. J Sur Res 2002;107:234-240
6. Emre MH, Erdogan H, Fadillioglu E. Effect of BQ-123 and nitric oxide inhibition on liver in rats after renal ischemia-reperfusion injury. Gen Physiol Biophys 2006;25:195-206.
7. Basireddy M, Isbell TS, Teng X, Patel RP, Agarwal A. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. Am J Physiol Renal Physiol 2006;290:F779-86.
8. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001;281:F948-57.
9. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004;66:491-496
10. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006;36:326-332
11. Erdogan H, Fadillioglu E, Yagmurca M, Uar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-46
12. Yildirim A, Gumus M, Dalga S, Sahin YN, Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Ann Clin Lab Sci 2003;33:459-464
13. Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 1995;358:219-224
14. Vila Petroff MG, Egan JM, Wang X, Sollott SJ. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 2001;89:445-452
15. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 2005;54:146-151
16. Bose AK, Mocanu MM, Carr RD, Yellon DM. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther 2005;19:9-11.
17. Bose AK, Mocanu MM, Carr RD, Yellon DM. Myocardial Ischaemia reperofusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In vitro Rat Heart and may Involve the p70s6K Pathway. Cardiovasc Drugs Ther 2007;21:253-256
18. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-229
19. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro. Biochem J 1971;123:805-814
20. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78. (Pubitemid 9065588)
21. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay of SOD. J Biol Chem 1972;247:3170-3175
22. Aebi H. Oxidoreductases acting on groups other than CHOH: Catalase. In: Colowick SP, Kaplan NO, Packer L, editors. Methods in Enzymology. London: Academic Press; 1984. p. 105:121-5.
23. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte peroxidase. J Lab Clin Med 1967;2:158-169
24. Prajda N, Weber G. Malign transformation-linked imbalance: Decreased XO activity in hepatomas. FEBS Lett 1975;59:245-249
25. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998;274:177-188
26. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993;14:1195-1201
27. Matsuyama M, Yoshimura R, Hase T, Kawahito Y, Sano H, Nakatani T. Study of cyclooxygenase-2 in renal ischemia-reperfusion injury. Transplant Proc 2005;37:370-372
28. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. In: Packer L, Glazer AN, editors. Methods in Enzymology, Oxygen radicals in biological systems. Vol.186. California: Academic Press; 1990. p. 464-478
29. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549-1558
30. Arnhold J, Osipov AN, Spalteholz H, Panasenko OM, Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001;31:1111-1119
31. Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004;348:27-34. (Pubitemid 39208997)
32. Sudnikovich EJ, Maksimchik YZ, Zabrodskaya SV, Kubyshin VL, Lapshina EA, Bryszewska M, et al. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats. Eur J Pharmacol 2007;569:180-187
33. Madar Z, Kalet-Litman S, Stark AH. Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats. Pharmacology 2004;73:106-112
34. Stadler K, Jenei V, von Bolcshazy G, Somogyi A, Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med 2003;35:1240-1251
35. Evelson P, Susemihl C, Villarreal I, Llesuy S, Rodriguez R, Peredo H, et al. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann Hepatol 2005;4:115-120
36. Kurcer Z, Parlakpinar H, Vardi N, Tasdemir S, Iraz M, Fadillioglu E, et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 2007;115:365-371